Dr. Maria Alejandra Caravedo Martinez, MD

Dr. Caravedo Martinez practices at Midc in Florence, Alabama.

Dr. Caravedo Martinez's NPI, 1801242276, was assigned on May 4, 2016. Dr. Caravedo Martinez holds Texas license T4719.

Dr. Caravedo Martinez's primary practice is Midc, at 123 Ana Dr, Florence, AL 35630 in Lauderdale County. The practice phone is (888) 220-6432.

Dr. Caravedo Martinez's primary practice is Midc in Florence, Alabama. Dr. Caravedo Martinez is also affiliated with North Alabama Medical Center. The medical group on file is Metro Infectious Disease Consultants. Dmand AI also links Dr. Caravedo Martinez to 3 more hospitals, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caravedo Martinez practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Caravedo Martinez's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Caravedo Martinez is licensed in Texas.

CMS data shows 339 Medicare services from Dr. Caravedo Martinez across 3 procedure codes in 2024, for 131 Medicare patients. Medicare paid $29,614 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Dr. Caravedo Martinez in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Caravedo Martinez's median patient age at 66, with 51% women.

In 2024, Dr. Caravedo Martinez wrote 216 Medicare Part D claims for 56 patients. 73% of them were for generic drugs. CMS names the drug for 63 of them, across 3 drugs with 11 or more claims each, at $96,740 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

Dr. Caravedo Martinez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Caravedo Martinez as offering telehealth.

Dmand AI links 4 papers to Dr. Caravedo Martinez, published from 2020 to 2025. Dr. Caravedo Martinez's most frequent co-authors are Lucas Scott Blanton, MD and Miguel Mauricio Cabada, MD, MS.

CMS Open Payments shows 1 general payment to Dr. Caravedo Martinez from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Insmed, Inc. paid the most, $14.